Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 7/20 | 0.45 |
| ▸ | CTSS | P25774 | 3/20 | 0.45 |
| ▸ | GRN | P28799 | 1/20 | 0.43 |
| ▸ | SORT1 | Q99523 | 1/20 | 0.43 |
| ▸ | CTSL | P07711 | 6/20 | 0.41 |
| ▸ | CTSB | P07858 | 5/20 | 0.41 |
| ▸ | PADI1 | Q9ULC6 | 1/20 | 0.40 |
| ▸ | PADI4 | Q9UM07 | 1/20 | 0.40 |
| ▸ | CTSH | P09668 | 2/20 | 0.40 |
| ▸ | LTA4H | P09960 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | CNR2 | P34972 | 2/20 | 0.39 |
| ▸ | CPB2 | Q96IY4 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23052492 | 0.87 | REN (0.44) | CTSKCTSSGRNSORT1CTSL | |
| SCHEMBL16684111 | 0.83 | CTSK (0.44) | CTSKCTSSGRNSORT1CTSL | |
| SCHEMBL4241732 | 0.83 | GRN (0.40) | CTSKCTSSGRNSORT1CTSL | |
| SCHEMBL28563624 | 0.83 | GRN (0.40) | CTSKCTSSGRNSORT1CTSL | |
| Hydrochloric Acid SCHEMBL15543179 | 0.81 | CHRNB2 (0.43) | CTSKCTSSGRNSORT1CPB2 | |
| Hydrochloric Acid SCHEMBL15543180 | 0.81 | CHRNB2 (0.43) | CTSKCTSSGRNSORT1CPB2 | |
| SCHEMBL23513830 | 0.81 | CTSK (0.47) | CTSKCTSSCTSLCTSBCTSH | |
| SCHEMBL18435573 | 0.81 | CTSK (0.47) | CTSKCTSSCTSLCTSBCTSH | |
| SCHEMBL4960993 | 0.81 | MMP1 (0.44) | CTSKCTSSCTSLCTSBLTA4H | |
| SCHEMBL27182937 | 0.81 | MMP1 (0.44) | CTSKCTSSCTSLCTSBLTA4H |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230159453-A1 | INHIBITORS OF NOROVIRUS AND CORONAVIRUS REPLICATION | COCRYSTAL PHARMA, INC. | 2023-05-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230159453-A1 | INHIBITORS OF NOROVIRUS AND CORONAVIRUS REPLICATION | VIM, ACE, ACE2 | CTSK 2355/4885CTSS 135/4885GRN 2468/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.